Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software

IT & Software

Plandai Biotechnology's technology could prove potent in battling alzheimers disease In the recently released preliminary results from Plandaí Biotechnology's human clinical trial that compared its green tea extract to a commercially available extract, Professor Anne Grobler and her team at North West University in South Africa proved that all 8 catechins found in the green tea plant were absorbed into the bloodstream of those using Phytofare Catechin Complex, including, the most potent catechin of the eight, epigallocatechin-3-gallate or EGCG.
Automation > IT & Software > News
MedImmune’s Phase I OX40 agonist trial uses AgonOx’s OX40 platform By PBR Staff Writer
US-based biotechnology firm AgonOx has announced that its OX40 platform is being used in AstraZeneca's global biologics research and development arm MedImmune’s Phase I trial of its humanized OX40 agonist, MEDI6383.
Automation > IT & Software > News Aduro expands deal with Janssen to develop product candidates for lung cancer By PBR Staff Writer
Aduro BioTech has entered into its second agreement with Janssen Biotech, granting an exclusive, worldwide license to certain product candidates designed to treat lung cancer and certain other cancers based on its novel LADD immunotherapy platform.
Automation > IT & Software > News
See more IT & Software news

Latest IT & Software News and Insight

View all IT & Software news or find news targeted to your interests
Aduro expands deal with Janssen to develop product candidates for lung cancer
By PBR Staff Writer
Aduro BioTech has entered into its second agreement with Janssen Biotech, granting an exclusive, worldwide license to certain product candidates designed to treat lung cancer and certain other cancers based on its novel LADD immunotherapy platform.
Automation > IT & Software > News
Immune Design, Sanofi Pasteur to develop herpes simplex virus therapy
By PBR Staff Writer
US-based clinical-stage immunotherapy firm Immune Design and Sanofi Pasteur have entered into a collaboration to develop a herpes simplex virus (HSV) immune therapy.
Automation > IT & Software > News
Nuvilex gets worldwide license for insulin-producing cells from University of Technology for use in developing diabetes treatment
Nuvilex has entered into a license with the University of Technology in Sydney, Australia (UTS), that grants Nuvilex the worldwide rights to use human insulin-producing cells, termed "Melligen" cells, developed by Prof. Ann Simpson and her colleagues at UTS for the development of a treatment for insulin-dependent (Type 1 or juvenile-onset) diabetes.
Automation > IT & Software > News
MorphoSys acquires Lanthio's lanthipeptide technology
By PBR Staff Writer
MorphoSys has exercised an option with Lanthio Pharma to acquire its lanthipeptide technology for drug discovery.
Automation > IT & Software > News
Orgenesis receives patent for potential cure for type 1 diabetes
Orgenesis, a leader in the emerging fields of cellular therapy and regenerative medicine, has announced that it has received a patent for the technology supporting its unique cell-based therapy, which is being developed as a potential cure for Type 1 Diabetes.
Automation > IT & Software > News
Portal Instruments completes landmark $11m series A financing for new drug delivery platform
Portal Instruments, a new dynamic, emerging leader in the development of innovative drug delivery systems, has completed a landmark $11m Series A financing led by Sanofi through its Sunrise initiative along with PBJ Capital (a Boston-based venture firm) and a major US medical device company.
Automation > IT & Software > News
FDA renews research contract with Symphony Health Solutions for outpatient prescription and drug utilization data
Symphony Health Solutions, a provider of high-value market research, analytics and technology solutions for healthcare and life science manufacturers, researchers, payers and providers, has announced that the company was awarded a $16.3m contract by the Food and Drug Administration (FDA) to provide estimates of the numbers of patients exposed to prescription drugs and the numbers of prescriptions dispensed nationwide in the outpatient setting.
Automation > IT & Software > News
Pharmaceutical organizations using new technologies for successful oncology product launches
Recent pharmaceutical product launches have had both noteworthy successes and failures – especially in the oncology therapeutic area.
Automation > IT & Software > News
Neos Therapeutics gets key patent covering extended release oral disintegrating tablet (XR-ODT) platform technology
Neos Therapeutics, a specialty pharmaceutical company with a portfolio of novel and proprietary oral drug delivery technologies as well as a late-stage pipeline of innovative extended release products for Attention Deficit Hyperactivity Disorder, has been granted a key patent (US Patent No. 8,840,924) covering its XR-oral disintegrating tablet technology, known as Rapidly Disintegrating Ionic Masking.
Automation > IT & Software > News
Aphios granted US patent for nanotechnology formulation of poorly soluble drugs
Aphios has announced that it has been granted United States Patent No. 8,703,727 entitled “Nanotechnology Formulation of Poorly Soluble Compounds,” for difficult to formulate and deliver drugs.
Automation > IT & Software > News
View all IT & Software news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250